Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Test material form:
solid: crystalline
Details on test material:
The dose preparations were corrected for purity (68.9%)

Method

Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
Liver S9 from phenobarbital/beta-naphthaflavone induced male rats
Test concentrations with justification for top dose:
5000, 2500, 1000, 500, 200, 100 ug/plate
Vehicle / solvent:
DMSO
Controls
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
Positive controls:
yes
Positive control substance:
sodium azide
N-ethyl-N-nitro-N-nitrosoguanidine
mitomycin C
other: Acridine, 2-aminoanthracene and Daunamycin
Details on test system and experimental conditions:
HMBDA was assayed using standard plate incorporation protocol both in the presence and absence of liver S9-mix prepared from phenobarbital/beta-naphthaflavone induced rats. HMBDA was subsequently re-tested in all 6 strains over the same dose range. The +S9 phase of the second assay was conducted using the preincubation protocol.
Evaluation criteria:
Test data are considered valid if: (a) the concurrent solvent control data are acceptable (b) the positive control data show unequivocal positive responses (c) at least the lowest test compound dose shows no evidance of toxicity and at least 3 test doses show significant toxicity. Failure of one or more test strain/S9 combinations does not invalidate the data for the remainder of a concurrent experiment. A positive response is achieved when (a) a statistically significant dose related increase in mean number of revertant colonies is obtaines, and/or (b) a 2 fold or greater increase in the mean number of revertant colonies (compared to the concurrent solvent plate) which is statistically signigicant is observed at at least 1 dose level. A negative result is achieve when (a) there is no statistically significant dose related increase in mean number of revertant colonies per plate and (b) in the absence of any such dose response, no increase in colony numbers is observed which exceeds 2x concurrent solvent control. For a positive response to be considered unequivocal i.e. mutagenic the observed effect muct be consistently reproducible.
Statistics:
An assessment of statistical significance was carried out using a one tailed student's t test. The corresponding probability for each dose level was derived by computer using the appropriate degrees of freedom. Values of p<0.01 are treated as significant, with calues of 0.01

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Positive controls validity:
valid
Additional information on results:
In 2 separate assays HMBDA did not induce any significant reproducible increases in the observed number of revertant colonies in strains TA1535, TA1537, TA98, TA100, WP2P and WP2P uvrA either in the presence or absence of S9. The positive controls for each experiment induced the expected responses indicating the strains were responding satisfactorily in each case.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

HMBDA was considered non-mutagenic to bacterial in vitro.